| Literature DB >> 26645312 |
Lingyun Wu1, Anxin Wang2,3,4,5,6, Xianwei Wang7,8,9,10, Xingquan Zhao11,12,13,14, Chunxue Wang15,16,17,18, Liping Liu19,20,21,22, Huaguang Zheng23,24,25,26, Yongjun Wang27,28,29,30, Yibin Cao31, Yilong Wang32,33,34,35.
Abstract
BACKGROUND: Stroke recurrence and disability in patients with a minor stroke is one of the most depressing medical situations. In this study, we aimed to identify which factors were associated with adverse outcomes of a minor stroke.Entities:
Mesh:
Year: 2015 PMID: 26645312 PMCID: PMC4673844 DOI: 10.1186/s12883-015-0505-z
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1Flow chart showing the patient selection. NIHSS, National Institutes of Health Stroke Scale
Univariate analysis of patients with or without stroke recurrence at 3 months after minor stroke
| Variables | Overall | Recurrence | No recurrence |
|
|---|---|---|---|---|
| Sample size, n (%) | 4669 | 459 (9.8) | 4210 (90.2) | |
| Age, median (IQR), year | 65 (55–74) | 67 (57–76) | 65 (55–73) | <0.001 |
| Female, n (%) | 1656 (35.5) | 159 (34.6) | 1497 (35.6) | 0.70 |
| Vascular risk factors | ||||
| Hypertension, n (%) | 3438 (73.6) | 365 (79.5) | 3073 (73.0) | 0.003 |
| Diabetes mellitus, n (%) | 1274 (27.3) | 148 (32.2) | 1126 (26.8) | 0.01 |
| Dyslipidemia, n (%) | 550 (11.8) | 68 (14.8) | 482 (11.4) | 0.03 |
| Atrial fibrillation, n (%) | 270 (5.8) | 53 (11.6) | 217 (5.2) | <0.001 |
| Treated atrial fibrillation, n (%) | 29 (10.7) | 4 (7.5) | 25 (11.5) | 0.55 |
| Coronary heart disease, n (%) | 600 (12.8) | 90 (19.6) | 510 (12.1) | <0.001 |
| Previous stroke, n (%) | 1451 (31.1) | 196 (42.7) | 1255 (29.8) | <0.001 |
| Current or previous smoking, n (%) | 1872 (40.1) | 178 (38.8) | 1694 (40.2) | 0.54 |
| Moderate or heavy alcohol, n (%) | 470 (10.1) | 47 (10.2) | 423 (10.0) | 0.90 |
| BMI at admission, median (IQR), kg/m2 | 24.22 (22.3–26.3) | 24.22 (22.4–26.6) | 24.22 (22.3–26.3) | 0.41 |
| NIHSS score, median (IQR) | ||||
| At admission | 2 (1–3) | 1 (0–2) | 2 (1–3) | 0.001 |
| At 24 h | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.74 |
| Time from onset to admission <24 h, n (%) | 2472 (52.9) | 263 (57.3) | 2209 (52.5) | 0.049 |
| Neurological deterioration, n (%) | 166 (3.6) | 31 (6.8) | 135 (3.2) | <0.001 |
| TOAST subtype, n (%) | <0.001 | |||
| Large-artery atherosclerosis | 1951 (41.8) | 208 (45.3) | 1743 (41.4) | |
| Small-artery occlusion | 1066 (22.8) | 84 (18.3) | 982 (23.3) | |
| Cardioembolism | 131 (2.8) | 28 (6.1) | 103 (2.4) | |
| Other | 176 (3.8) | 13 (2.8) | 163 (3.9) |
IQR interquartile range, NIHSS National Institutes of Health Stroke Scale, BMI body mass index, TOAST Trial of Org 10172 in Acute Stroke Treatment
Univariate analysis of patients with or without stroke disability at 3 months after minor stroke
| Variables | Overall | Disability | No disability |
|
|---|---|---|---|---|
| Sample size, n (%) | 4669 | 679 (14.5) | 3990 (85.5) | |
| Age, median (IQR), year | 65 (55–74) | 72 (62–78) | 64 (55–72) | <0.001 |
| Female, n (%) | 1656 (35.5) | 281 (41.4) | 1375 (34.5) | <0.001 |
| Vascular risk factors | ||||
| Hypertension, n (%) | 3438 (73.6) | 527 (77.6) | 2911 (73.0) | 0.01 |
| Diabetes mellitus, n (%) | 1274 (27.3) | 251 (37.0) | 1023 (25.6) | <0.001 |
| Dyslipidemia, n (%) | 550 (11.8) | 79 (11.6) | 471 (11.8) | 0.90 |
| Atrial fibrillation, n (%) | 270 (5.8) | 75 (11.0) | 195 (4.9) | <0.001 |
| Coronary heart disease, n (%) | 600 (12.8) | 124 (18.3) | 476 (11.9) | <0.001 |
| Previous stroke, n (%) | 1451 (31.1) | 273 (40.2) | 1178 (29.5) | <0.001 |
| Current or previous smoking, n (%) | 1872 (40.1) | 229 (33.7) | 1643 (41.2) | <0.001 |
| Moderate or heavy alcohol, n (%) | 470 (10.1) | 39 (5.7) | 431 (10.8) | <0.001 |
| BMI at admission, median (IQR), kg/m2 | 24.22 (22.3–26.3) | 24.03 (22.0–26.0) | 24.22 (22.5–26.4) | 0.03 |
| NIHSS score, median (IQR) | ||||
| At admission | 2 (1–3) | 2 (0–3) | 2 (1–3) | 0.06 |
| At 24 h | 2 (1–3) | 3 (2–3) | 2 (1–3) | <0.001 |
| Time from onset to admission <24 h, n (%) | 2472 (52.9) | 1641 (54.5) | 831 (50.2) | 0.005 |
| Neurological deterioration, n (%) | 166 (3.6) | 270 (39.8) | 1927 (48.3) | <0.001 |
| TOAST subtype, n (%) | <0.001 | |||
| Large-artery atherosclerosis | 1951 (41.8) | 303 (44.6) | 1648 (41.3) | |
| Small-artery occlusion | 1066 (22.8) | 94 (13.8) | 972 (24.4) | |
| Cardioembolism | 131 (2.8) | 44 (6.5) | 87 (2.2) | |
| Other | 176 (3.8) | 21 (3.1) | 155 (3.9) |
Stroke disability was defined as modified Rankin Scale >2; IQR interquartile range, BMI body mass index, NIHSS National Institutes of Health Stroke Scale, TOAST Trial of Org 10172 in Acute Stroke Treatment
Univariate analysis of patients with or without all-cause death at 3 months after minor stroke
| Variables | Overall | Death | No death |
|
|---|---|---|---|---|
| Sample size, n (%) | 4669 | 168 (3.6) | 4501 (96.4) | |
| Age, median (IQR), year | 65 (55–74) | 72 (60–77) | 65 (55–73) | <0.001 |
| Female, n (%) | 1656 (35.5) | 70 (41.7) | 1586 (35.2) | 0.87 |
| Vascular risk factors | ||||
| Hypertension, n (%) | 3438 (73.6) | 122 (72.6) | 3316 (73.7) | 0.76 |
| Diabetes mellitus, n (%) | 1274 (27.3) | 46 (27.4) | 1228 (27.3) | 0.98 |
| Dyslipidemia, n (%) | 550 (11.8) | 21 (12.5) | 529 (11.8) | 0.77 |
| Atrial fibrillation, n (%) | 270 (5.8) | 25 (14.9) | 245 (5.4) | <0.001 |
| Coronary heart disease, n (%) | 600 (12.9) | 40 (23.8) | 560 (12.4) | <0.001 |
| Previous stroke, n (%) | 1451 (31.1) | 68 (40.5) | 1383 (30.7) | 0.007 |
| Current or previous smoking, n (%) | 1872 (40.1) | 62 (36.9) | 1810 (40.2) | 0.39 |
| Moderate or heavy alcohol, n (%) | 470 (10.1) | 11 (6.6) | 459 (10.2) | 0.12 |
| BMI at admission, median (IQR), kg/m2 | 24.22 (22.3–26.3) | 23.61 (21.7–26.0) | 24.22 (22.4–26.3) | <0.001 |
| NIHSS score, median (IQR) | ||||
| At admission | 2 (1–3) | 1 (0–2) | 2 (1–3) | <0.001 |
| At 24 h | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.006 |
| Time from onset to admission <24 h, n (%) | 2472 (52.9) | 97 (57.7) | 2375 (52.8) | 0.20 |
| Neurological deterioration, n (%) | 166 (3.6) | 19 (11.3) | 147 (3.3) | <0.001 |
| TOAST subtype, n (%) | <0.001 | |||
| Large-artery atherosclerosis | 1951 (41.8) | 66 (39.3) | 1855 (41.9) | |
| Small-artery occlusion | 1066 (22.8) | 19 (11.3) | 1047 (23.3) | |
| Cardioembolism | 131 (2.8) | 15 (8.9) | 116 (2.6) | |
| Other | 176 (3.8) | 5 (3.0) | 171 (3.8) |
IQR interquartile range, BMI body mass index, NIHSS National Institutes of Health Stroke Scale, TOAST Trial of Org 10172 in Acute Stroke Treatment
Fig. 2The adjusted ORs for stroke recurrence, disability and death at 3 months after stroke onset. Stroke disability was defined as modified Rankin Scale > =3.OR denotes Odds Ratio; CI, Confidence Internal; BMI, Body Mass Index. Adjusted for age, gender, hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, coronary heart disease, previous stroke, current or previous smoking, moderate or heavy alcohol, BMI at admission, and admission within 24 h